Results 11 to 20 of about 1,358,747 (402)

Atraumatic Ruptured Giant Renal Tumor [PDF]

The Annals of African Surgery, 2020
Massive hemoperitoneum due to spontaneous rupture of renal cell carcinoma is a rare presentation during emergency laparotomy. A 60-year-old female patient presented with severe abdominal pain, nausea, vomiting and abdominal distension.
Ayane, Gezahen Negusse, Kadimo, Khutsafalo   +1 more
core   +4 more sources

Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma [PDF]

Diagnostic Pathology, 2007
Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma. Classical and eosinophilic types are the two histological variants recorded.
Carlos González, Isabel Rodrigo, Teresa Pereda, Rafael Funez, Luis Robles   +4 more
openaire   +5 more sources

Gallbladder Metastasis from Renal Cell Carcinoma [PDF]

Case Reports in Oncology, 2010
A 73-year-old female was operated with radical nephrectomy and cholecystectomy for renal cell carcinoma and suspected gallstones after 9 courses of sunitinib treatment.
Furuya, Mitsuko, Hayashi, Narihiko, Itoh, Hiroki, Kawahara, Takashi, Kawaji, Kaoru, Kubota, Yoshinobu, Makiyama, Kazuhide, Nakaigawa, Noboru, Namura, Kazuhiro, Ogawa, Takehiko, Ohshiro, Hisashi, Sano, Futoshi, Sekiguchi, Zenkichi, Uemura, Hiroji, Yao, Masahiro   +14 more
core   +8 more sources

Thyroid-like Follicular Carcinoma of the Right Kidney: A Case Report [PDF]

Middle East Journal of Cancer, 2019
Renal cell carcinoma is responsible for approximately 80% of malignant tumors of the kidney. Clear cell, papillary, and chromophobe forms comprise the most frequent histological subtypes of renal cell carcinoma.
Mohammad Hossein Sanei, Behnaz Sabaghi, Roya Sedighin, Saeedeh Alamdari, Maryam Katani   +4 more
doaj   +3 more sources

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

New England Journal of Medicine, 2021
BACKGROUND Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear. METHODS In this phase 3 trial, we randomly assigned (
R. Motzer, B. Alekseev, S. Rha, C. Porta, M. Eto, T. Powles, V. Grünwald, Thomas E. Hutson, E. Kopyltsov, M. Méndez-Vidal, V. Kozlov, A. Alyasova, Sung-Hoo Hong, A. Kapoor, Teresa Alonso Gordoa, J. Merchan, E. Winquist, P. Maroto, J. Goh, Miso Kim, H. Gurney, V. Patel, A. Peer, G. Procopio, T. Takagi, B. Melichar, F. Rolland, U. de Giorgi, Shirley S. Wong, J. Bedke, M. Schmidinger, C. Dutcus, Alan D. Smith, L. Dutta, K. Mody, R. Perini, D. Xing, T. Choueiri   +37 more
semanticscholar   +1 more source

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

New England Journal of Medicine, 2021
BACKGROUND The efficacy and safety of nivolumab plus cabozantinib as compared with those of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not known.
T. Choueiri, T. Powles, M. Burotto, B. Escudier, M. Bourlon, B. Żurawski, V. O. Oyervides Juarez, J. Hsieh, U. Basso, A. Shah, C. Suarez, A. Hamzaj, J. Goh, C. Barrios, M. Richardet, C. Porta, R. Kowalyszyn, Juan P Feregrino, J. Zolnierek, D. Pook, E. Kessler, Y. Tomita, R. Mizuno, J. Bedke, Joshua Zhang, M. Maurer, B. Simsek, F. Ejzykowicz, G. Schwab, A. Apolo, R. Motzer   +30 more
semanticscholar   +1 more source

Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a

Frontiers in Oncology, 2022
BackgroundRenal cell carcinoma is the most common malignant tumor of the kidney. The 5-year survival of renal cell carcinoma with distant metastasis is very low.
Yang Liu, Yang Liu, Weiwei Cui, Ruihong Zhang, Sujuan Zhi, Lanlan Liu, Xuyue Liu, Xiaoning Feng, Yanru Chen, Xiaoli Zhang, Jing Hao   +10 more
doaj   +1 more source

New trends and future prospects of regulatory cell death in renal carcinoma [PDF]

Zhongguo aizheng zazhi, 2022
Renal cell carcinoma is one of the most common malignancies in genitourinary cancers. In China, the incidence of renal cell carcinoma has been increasing year by year.
CAO Dalong, YE Dingwei
doaj   +1 more source

Metastatic Renal Cell Carcinoma to Duodenum and Pancreas 10 Years After Nephrectomy: A Case Report

Case Reports in Clinical Practice, 2023
Renal cell carcinoma (RCC) accounts for 2-3% of the malignant tumors in adult patients. The most common sites of metastasis are the lung, bone, liver and brain respectively.
Mahsa Akbari Oryani, Azade Zare, Mohsen Soltani Sabi, Mohammad Taghi Mashhadi-Rajabi   +3 more
doaj   +1 more source

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nature Network Boston, 2022
Previous studies have suggested that the gut microbiome influences the response to checkpoint inhibitors (CPIs) in patients with cancer. CBM588 is a bifidogenic live bacterial product that we postulated could augment CPI response through modulation of ...
N. Dizman, L. Meza, P. Bergerot, Marice B. Alcantara, T. Dorff, Y. Lyou, P. Frankel, Yujie Cui, Valerie Mira, M. Llamas, J. Hsu, Z. Zengin, N. Salgia, S. Salgia, J. Malhotra, N. Chawla, A. Chehrazi-Raffle, R. Muddasani, J. Gillece, L. Reining, Jeff Trent, Motomichi Takahashi, K. Oka, S. Higashi, M. Kortylewski, S. Highlander, S. Pal   +26 more
semanticscholar   +1 more source